推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CANCER RESEARCH 期刊收藏夹

2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   IF范围: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
Wiley 2026暑期线上学习营 | 报名正式开启!
最高IF18.6!生命科学SCI明星期刊集锦
肿瘤免疫/自身免疫全覆盖|免疫学SCI期刊列表

按研究方向查看:


CANCER RESEARCH期刊基本信息Hello,您是该期刊的第408994位访客


基本信息 登录收藏
期刊名字CANCER RESEARCHCANCER RESEARCH

CANCER RES
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
9.3
64人评分
我要评分

声誉
9.8

影响力
8.9

速度
8.9

期刊ISSN0008-5472
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
E-ISSN1538-7445
2025-2026最新IF
(数据来源于网友提供)
注册登录后,查看IF
实时影响因子 截止2026年5月06日:21.4
2025-2026自引率0.9%点击查看自引率趋势图
五年IF
(数据来源于网友提供)
15.704数据由网友[坚强南方]收集提供
h-index 411
CiteScore
2026年6月最新版
CiteScoreSJRSNIPCiteScore排名
17.004.3471.931
学科分区排名百分位
大类:Medicine
小类:Oncology
Q125 / 428
大类:Medicine
小类:Cancer Research
Q119 / 233

期刊简介
Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention and epidemiological research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology.
期刊官方网站http://cancerres.aacrjournals.org/
期刊投稿格式模板
VIP专享
Word版格式模板  
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
 
期刊投稿网址http://can.msubmit.net/cgi-bin/main.plex
该期刊中国学者近期发文 - NewIntratumoral Prevotella copri Reprograms MARCO+ Tumor-Associated Macrophages by Depleting Glycerophosphocholine to Drive Colorectal Cancer Progression
Author: Yuan, Qihang; Sun, Yushan; Zhang, Yue; Chen, Chen; Bu, Chenye; Hua, Xiaolong; Sun, Lejia; Sun, Yueming; Zhang, Zhan; Feng, Yifei
Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2414-2428. DOI: 10.1158/0008-5472.CAN-25-3400


Serglycin Drives LAG3+ Treg Differentiation and Immunosuppression in Gastric Cancer
Author: Wang, Qingyuan; Xu, Peng; Chen, Jia; Yang, Sheng; Li, Xiang; Wang, Yaohui; Hua, Hongjin; Ping, Xiaochun; Shen, Jiajia; Shen, Lizong
Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2395-2413. DOI: 10.1158/0008-5472.CAN-25-3071


NSD1-Mediated PPARγ Methylation Enhances PTEN Activity to Suppress Glycolysis and Tumor Progression in Endometrial Cancer
Author: Tao, Han; Gu, Ye; Wang, Xiaojun; Sun, Yeli; Wang, Luhui; Dai, Yilin; Zhu, Mengyue; Hu, Zhiyi; Li, Yiran; Kong, Mengwen; Gao, Kun; Wan, Xiaoping
Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2464-2486. DOI: 10.1158/0008-5472.CAN-25-3289


AKT3-Driven Epithelial-Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Author: Shi, Jingyi; Wang, Xiaowen; Zhang, Wutong; Gao, Zhaoya; Zhang, Chang; Tao, Zixin; Yang, Yong; Xu, Jingxuan; Hong, Haopeng; Ma, Yunan; Chen, Baojun; Wang, Yunfan; Ji, Dengbo; Li, Ming; Jia, Guifang; Gu, Jin
Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2537-2554. DOI: 10.1158/0008-5472.CAN-25-1718


期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER RESEARCH的语言要求,还能让CANCER RESEARCH编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(2篇) 论文致谢(6篇)
提交文稿
是否OA开放访问No
通讯方式AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404
出版商American Association for Cancer Research Inc.
涉及的研究方向医学-肿瘤学
出版国家或地区UNITED STATES
出版语言English
出版周期Semimonthly
出版年份1941
年文章数 291点击查看年文章数趋势图
Gold OA文章占比35.17%
研究类文章占比:
文章 ÷(文章 + 综述)
93.47%
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 3区1区1区
ONCOLOGY
肿瘤学
1区3区1区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区1区
ONCOLOGY
肿瘤学
3区2区1区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区1区
ONCOLOGY
肿瘤学
1区3区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0008-5472%5BISSN%5D
平均审稿速度网友分享经验:
平均2.5月
平均录用比例网友分享经验:
约30%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CANCER RESEARCH顺利发表。
快看看作者怎么说吧:服务好评(2篇) 论文致谢(6篇)
提交文稿
期刊常用信息链接
同领域相关期刊 CANCER RESEARCH期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CANCER RESEARCH期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CANCER RESEARCH上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    Nature Reviews Clinical Oncology127126.60
    ANNALS OF ONCOLOGY21069.60
    NATURE REVIEWS CANCER39696.20
    CANCER CELL29575.40
    JOURNAL OF CLINICAL ONCOLOGY49414.20
    LANCET ONCOLOGY27442.00
    SEMINARS IN CANCER BIOLOGY13442.00
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6722.30
    CANCER AND METASTASIS REVIEWS13416.30
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE903374
    JOURNAL OF ETHNOPHARMACOLOGY806857
    Frontiers in Immunology752177
    BIOMEDICINE & PHARMACOTHERAPY729071
    Frontiers in Pharmacology719677
    BIOMATERIALS718412
    PHYTOMEDICINE648569
    Frontiers in Oncology623203
    Biomedical Signal Processing and Control605880
    IEEE Journal of Biomedical and Health Informatics601731
  •  

    CANCER RESEARCH CANCER RESEARCH
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Intratumoral Prevotella copri Reprograms MARCO+ Tumor-Associated Macrophages by Depleting Glycerophosphocholine to Drive Colorectal Cancer Progression

    Author: Yuan, Qihang; Sun, Yushan; Zhang, Yue; Chen, Chen; Bu, Chenye; Hua, Xiaolong; Sun, Lejia; Sun, Yueming; Zhang, Zhan; Feng, Yifei
    Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2414-2428. DOI: 10.1158/0008-5472.CAN-25-3400
        PubMed      DOI
    2.Serglycin Drives LAG3+ Treg Differentiation and Immunosuppression in Gastric Cancer

    Author: Wang, Qingyuan; Xu, Peng; Chen, Jia; Yang, Sheng; Li, Xiang; Wang, Yaohui; Hua, Hongjin; Ping, Xiaochun; Shen, Jiajia; Shen, Lizong
    Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2395-2413. DOI: 10.1158/0008-5472.CAN-25-3071
        PubMed      DOI
    3.NSD1-Mediated PPARγ Methylation Enhances PTEN Activity to Suppress Glycolysis and Tumor Progression in Endometrial Cancer

    Author: Tao, Han; Gu, Ye; Wang, Xiaojun; Sun, Yeli; Wang, Luhui; Dai, Yilin; Zhu, Mengyue; Hu, Zhiyi; Li, Yiran; Kong, Mengwen; Gao, Kun; Wan, Xiaoping
    Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2464-2486. DOI: 10.1158/0008-5472.CAN-25-3289
        PubMed      DOI
    4.AKT3-Driven Epithelial-Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling

    Author: Shi, Jingyi; Wang, Xiaowen; Zhang, Wutong; Gao, Zhaoya; Zhang, Chang; Tao, Zixin; Yang, Yong; Xu, Jingxuan; Hong, Haopeng; Ma, Yunan; Chen, Baojun; Wang, Yunfan; Ji, Dengbo; Li, Ming; Jia, Guifang; Gu, Jin
    Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2537-2554. DOI: 10.1158/0008-5472.CAN-25-1718
        PubMed      DOI
    5.Targeting LRRC15 in Cancer-Associated Fibroblasts Modifies the Extracellular Matrix and Enhances Tumor Immune Responses to Suppress Lung Cancer Progression

    Author: Qi, Lu; Dang, Guohui; Ling, Xinnan; Miao, Yuhui; Bo, Yufei; Zhai, Yuhang; Chen, Xiaowei; Zhai, Qianting; Zheng, Liangtao; Zhang, Yu; Li, Yanjie; Liu, Chang; Fan, Hongtao; Si, Wen; Tong, Dan; Yang, Zhenlin; Hu, Xueda; Wang, Dongfang; Cheng, Sijin; Zhang, Zemin; Zhu, Linnan
    Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2377-2394. DOI: 10.1158/0008-5472.CAN-25-2871
        PubMed      DOI
    6.GAL3ST1-Mediated Histone Tyrosine Sulfation Induced by Cancer-Associated Fibroblasts Promotes Gastric Cancer Metastasis

    Author: Lu, Yifan; Wu, Xiongyan; Li, Baolong; Yao, Lizhong; Hou, Junyi; Yu, Beiqin; Li, Jianfang; Li, Chen; Yan, Min; Yang, Zhongyin; Yan, Chao; Zhu, ZhengGang; Liu, Bingya; Tang, Kaiwen; Pan, Tao; Yu, Zhenjia; Jin, Zhijian; Su, Liping
    Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2429-2446. DOI: 10.1158/0008-5472.CAN-25-2452
        PubMed      DOI
    7.ARID1A Mediates SWI/SNF-Independent Maintenance of Heterochromatin Architecture to Restrain Viral Mimicry and Immunogenicity in Colon Cancer

    Author: Li, Qian; Zhang, Zhe; Wang, Yihao; Peng, Xiangdong; Fang, Yan; Zhang, Yujun; Chen, Ling; Huang, Tingyu; Yang, Zhengduo; Li, Chunliang; Li, Lingjie; Mills, Gordon B.; Shen, Xuetong; Wang, Hongyan; Shen, Jianfeng
    Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2344-2359. DOI: 10.1158/0008-5472.CAN-25-3231
        PubMed      DOI
    8.Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Induced Neutrophil Extracellular Trap Formation

    Author: Li, Guanqun; Zhang, Can; Lu, Tianqi; Zhang, Ziwei; Wu, Jiafu; Bai, Rui; Luo, Yan; Wang, Fengyi; Song, Yiqin; Liu, Liwei; Hu, Jisheng; Wang, Yongwei; Wang, Gang; Tan, Hongtao; Chen, Hua; Kong, Rui; Li, Le; Sun, Bei
    Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 10, pp. 2327-2343. DOI: 10.1158/0008-5472.CAN-25-2854
        PubMed      DOI
    9.A first-in-human phase 1 trial of a novel claudin 6 (CLDN6)-targeting antibody drug conjugate (ADC) QLS5132 in patients (pts) with platinum-resistant ovarian cancer (PROC)

    Author: Xiang, Yang; Song, Zhengbo; Li, Juan; Chen, Liang; Sun, Yang; Zou, Dongling; Li, Yongsheng; Zhang, Songling; Ding, Yanhua; Gu, Yu; Liu, Xin; Zhang, Tao; Kang, Xiaoyan; Tao, Weikang; Zhu, Tao
    Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. CT037-CT037. DOI: 10.1158/1538-7445.AM2026-CT037
        DOI
    10.Safety and efficacy of Elisrasib (D3S-001), a next generation GDP-bound KRAS G12C inhibitor, as monotherapy in advanced non-small cell lung cancer (NSCLC) previously treated with or without a KRAS G12C inhibitor: Results from a phase 1/2 study

    Author: Cho, Byoung Chul; Lu, Shun; Li, Ziming; Park, John; Zhao, Jun; Fung Loong, Herbert Ho; Hollebecque, Antoine; Yang, Bin; Wang, Binchao; Chen, Cheng; Wang, Jia; Wang, Shaonan; Shen, Yandong; Fan, Zifei; Chen, Qian; Wang, Hui; Zhang, Jing; Jian Chen, George Zhi; Johnson, Melissa; Kam Mok, Tony Shu
    Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. CT020-CT020. DOI: 10.1158/1538-7445.AM2026-CT020
        DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    LANCET70092.40
    MMWR Surveillance Summaries093.20
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
    Nature Reviews Disease Primers4871.30
    World Psychiatry6184.80
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386165.20
    LANCET70092.40
    NATURE REVIEWS MICROBIOLOGY250124.00
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Nature Reviews Materials61110.60
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共446


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室